Literature DB >> 7332488

Type D retroviruses from human cells do not contain a minor glycoprotein shared by old world monkey type D viruses.

V Wunderlich, W Uckert.   

Abstract

The protein patterns of type D retroviruses isolated either from permanent human cells (HeLa virus, HeLa V, and HEp-2 virus, HEp-2V) or from spectacled langur (langur virus, LV), an Old World monkey, were investigated using sodium dodecyl sulfate polyacrylamide gel electrophoresis. Labeling with 14C-amino acids and 3H-glucosamine revealed for each of these isolates five polypeptides with molecular weights of 10,000, 12,000, 15,000, 25,000 and about 68,000 and identified the 68,000 D-protein as a glycoprotein. An additional glycoprotein with a molecular weight of 20,000 (gp20) was resolved in LV similarly as in previous studies with Mason-Pfizer monkey virus. However, in accordance with our recent analysis of a third type D isolate from human cells (PMFV), gp20 was not detectable in both HeLaV and HEp-2V regardless of the cell line in which they were grown. Thus, it appears that the type D virus isolates from human cells are slightly distinct from the presently known type D retroviruses of Old World monkeys. The relevance of this finding to the origin of the human isolates, however, remains to be shown.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7332488     DOI: 10.1007/bf01320792

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  Structural analysis of the genomes of gibbon ape and woolly monkey leukosis viruses.

Authors:  B G Sahagan; W A Haseltine
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  An oncornavirus isolated from human cancer cell line.

Authors:  K V Ilyin; A F Bykovsky; V M Zhdanov
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

3.  A new virus in a spontaneous mammary tumor of a rhesus monkey.

Authors:  H C Chopra; M M Mason
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

4.  Detection of oncornavirus-like particles in HeLa cells. I. Fine structure and comparative morphological classification.

Authors:  H Gelderblom; H Bauer; H Ogura; R Wigand; A B Fischer
Journal:  Int J Cancer       Date:  1974-02-15       Impact factor: 7.396

5.  Phosphorylation of murine type C viral p12 proteins regulates their extent of binding to the homologous viral RNA.

Authors:  A Sen; C J Sherr; G J Todaro
Journal:  Cell       Date:  1977-03       Impact factor: 41.582

6.  Mason-Pfizer monkey virus: analysis and localization of virion proteins and glycoproteins.

Authors:  G Schochetman; K Kortright; J Schlom
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

7.  Immunological and structural relationships between langur virus and other primate type-D retroviruses.

Authors:  D Colcher; Y A Teramoto; J Schlom
Journal:  Virology       Date:  1978-07-15       Impact factor: 3.616

Review 8.  Oncornaviruses type D and their possible role in neoplastic processes.

Authors:  F I Yershov; V M Zhdanov
Journal:  Prog Med Virol       Date:  1977

9.  The protein pattern of PMF virus, a type-D retrovirus from malignant permanent human cell lines.

Authors:  W Uckert; V Wunderlich; E Bender; G Sydow; D Bierwolf
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  Oncornavirus: isolation from a squirrel monkey (Saimiri sciureus) lung culture.

Authors:  R L Heberling; S T Barker; S S Kalter; G C Smith; R J Helmke
Journal:  Science       Date:  1977-01-21       Impact factor: 47.728

View more
  2 in total

1.  Further evidence from tryptic peptide analysis for heterogeneity among type D retroviruses.

Authors:  W Uckert; I Hertling; J Denner
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

2.  Biochemical and immunological characterization of structural proteins from retrovirus-D/New England and comparison to Mason-Pfizer monkey virus and permanent human fibroblast virus.

Authors:  W Uckert; V Wunderlich; H Fiebach; I Hertling; U Stein; R Kraft; R Desrosiers
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.